ICU Medical Return on Investment 2006-2018 | ICUI

Current and historical return on investment (ROI) values for ICU Medical (ICUI) over the last 10 years.
ICU Medical ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-09-30 $0.08B $1.26B 6.15%
2018-06-30 $0.07B $1.26B 5.79%
2018-03-31 $0.01B $1.23B 0.41%
2017-12-31 $-0.02B $1.20B -1.24%
2017-09-30 $-0.04B $1.22B -4.01%
2017-06-30 $-0.02B $1.20B -1.83%
2017-03-31 $0.04B $1.22B 5.35%
2016-12-31 $0.08B $0.66B 13.17%
2016-09-30 $0.08B $0.65B 13.44%
2016-06-30 $0.09B $0.62B 14.41%
2016-03-31 $0.08B $0.60B 14.38%
2015-12-31 $0.07B $0.58B 12.53%
2015-09-30 $0.07B $0.57B 12.76%
2015-06-30 $0.05B $0.54B 9.93%
2015-03-31 $0.04B $0.52B 7.99%
2014-12-31 $0.04B $0.51B 7.97%
2014-09-30 $0.04B $0.49B 8.56%
2014-06-30 $0.05B $0.49B 10.34%
2014-03-31 $0.05B $0.47B 11.19%
2013-12-31 $0.05B $0.47B 12.12%
2013-09-30 $0.06B $0.43B 13.89%
2013-06-30 $0.06B $0.42B 15.17%
2013-03-31 $0.06B $0.40B 16.59%
2012-12-31 $0.06B $0.39B 17.03%
2012-09-30 $0.07B $0.37B 19.91%
2012-06-30 $0.06B $0.35B 19.39%
2012-03-31 $0.06B $0.34B 20.08%
2011-12-31 $0.07B $0.32B 21.24%
2011-09-30 $0.05B $0.31B 18.38%
2011-06-30 $0.06B $0.31B 19.82%
2011-03-31 $0.05B $0.29B 20.22%
2010-12-31 $0.05B $0.27B 18.75%
2010-09-30 $0.04B $0.26B 16.13%
2010-06-30 $0.03B $0.25B 13.18%
2010-03-31 $0.03B $0.25B 11.75%
2009-12-31 $0.04B $0.27B 13.45%
2009-09-30 $0.04B $0.28B 15.49%
2009-06-30 $0.04B $0.27B 17.22%
2009-03-31 $0.04B $0.26B 16.65%
2008-12-31 $0.03B $0.25B 13.98%
2008-09-30 $0.03B $0.24B 11.93%
2008-06-30 $0.02B $0.23B 9.93%
2008-03-31 $0.02B $0.22B 10.38%
2007-12-31 $0.03B $0.21B 11.19%
2007-09-30 $0.02B $0.22B 10.17%
2007-06-30 $0.03B $0.23B 11.09%
2007-03-31 $0.03B $0.23B 12.26%
2006-12-31 $0.03B $0.23B 14.55%
2006-09-30 $0.03B $0.22B 16.18%
2006-06-30 $0.03B $0.21B 17.03%
2006-03-31 $0.03B $0.20B 16.30%
2005-12-31 $0.03B $0.19B 16.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.180B $1.293B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $131.725B 26.04
Medtronic (MDT) Ireland $124.003B 18.10
Stryker (SYK) United States $69.357B 25.46
Boston Scientific (BSX) United States $55.158B 26.93
Baxter (BAX) United States $39.096B 24.09
Zimmer Biomet Holdings (ZBH) United States $25.203B 16.17
Smith & Nephew SNATS (SNN) United Kingdom $16.703B 0.00
ResMed (RMD) United States $14.294B 27.11
Canopy Growth (CGC) Canada $10.770B 0.00
Bio-Rad Laboratories (BIO) United States $8.091B 51.74
Hill-Rom Holdings (HRC) United States $6.945B 21.48
Aurora Cannabis (ACB) Canada $6.920B 49.50
Perrigo (PRGO) Ireland $6.732B 10.22
Insulet (PODD) United States $5.177B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.529B 0.00
Haemonetics (HAE) United States $4.482B 39.76
Agios Pharmaceuticals (AGIO) United States $3.370B 0.00
Hutchison China MediTech (HCM) China $3.317B 0.00
Neogen (NEOG) United States $3.262B 50.11
NuVasive (NUVA) United States $2.949B 27.43
Quidel (QDEL) United States $2.670B 24.08
National Vision Holdings (EYE) United States $2.583B 49.97
Aphria (APHA) $2.429B 107.89
NxStage Medical (NXTM) United States $1.977B 0.00
AtriCure (ATRC) United States $1.267B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.213B 23.75
Cardiovascular Systems (CSII) United States $1.191B 854.75
HEXO (HEXO) $1.180B 0.00
MacroGenics (MGNX) United States $0.936B 0.00
Cerus (CERS) United States $0.886B 0.00
PetIQ (PETQ) United States $0.833B 21.60
Surmodics (SRDX) United States $0.773B 112.39
Lantheus Holdings (LNTH) United States $0.737B 19.96
Meridian Bioscience (VIVO) United States $0.728B 21.70
Evolus (EOLS) United States $0.725B 0.00
NanoString Technologies (NSTG) United States $0.718B 0.00
OraSure Technologies (OSUR) United States $0.707B 31.16
Omeros (OMER) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.624B 20.02
Quanterix (QTRX) United States $0.505B 0.00
Owens & Minor (OMI) United States $0.494B 6.84
LeMaitre Vascular (LMAT) United States $0.492B 23.46
Insys Therapeutics (INSY) United States $0.418B 0.00
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.322B 435.25
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Vapotherm (VAPO) United States $0.285B 0.00
Bovie Medical (APYX) United States $0.281B 0.00
Cytosorbents (CTSO) United States $0.259B 0.00
Rockwell Medical (RMTI) United States $0.253B 0.00
Zynex (ZYXI) United States $0.170B 16.42
Surface Oncology (SURF) United States $0.147B 0.00
Fonar (FONR) United States $0.146B 7.79
Chembio Diagnostics (CEMI) United States $0.116B 0.00
Chimerix (CMRX) United States $0.097B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.80
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.29